Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Renovorx Inc (RNXT)

4.06   -0.07 (-1.69%) 01-16 04:48
Open: 4.01 Pre. Close: 4.13
High: 4.144 Low: 3.93
Volume: 46,426 Market Cap: 36M
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Los Altos, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.149 - 4.174 4.174 - 4.192
Low: 3.872 - 3.904 3.904 - 3.928
Close: 4.017 - 4.065 4.065 - 4.101

Technical analysis

as of: 2022-01-15 8:49:25 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 6.11     One year: 7.14
Support: Support1: 3.81    Support2: 3.17
Resistance: Resistance1: 5.23    Resistance2: 6.11
Pivot: 4.48
Moving Average: MA(5): 4.19     MA(20): 4.64
MA(100): -10000000000.00 -10000000000    MA(250):
MACD: MACD(12,26): -0.45     Signal(9): -0.45
Stochastic oscillator: %K(14,3): 21.91     %D(3): 26.09
RSI: RSI(14): 33.44
52-week: High: 16.74  Low: 3.81  Change(%): -44.1
Average Vol(K): 3-Month: 289645  10-Days: 17504

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
RNXT has closed above bottom band by 20.8%. Bollinger Bands are 0% narrower than normal.

Headline News

Thu, 06 Jan 2022
RenovoRx to Present at the H.C. Wainwright Bioconnect Virtual Conference - Business Wire

Thu, 06 Jan 2022
Zacks Investment Research Downgrades RenovoRx (NASDAQ:RNXT) to Hold - MarketBeat

Mon, 29 Nov 2021
We Think RenovoRx (NASDAQ:RNXT) Can Afford To Drive Business Growth - Simply Wall St

Mon, 15 Nov 2021
$RNXT RenovoRx Says As Of Sept 30, Co Had Cash, Cash Equivalents Of $17.7 Mln And No Outstanding Debt Obligations - CML News

Mon, 15 Nov 2021
RenovoRx Announces Third Quarter 2021 Financial Results - Business Wire

Wed, 10 Nov 2021
30 Stocks Moving in Wednesday's Pre-Market Session - Benzinga - Benzinga

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 9
Shares Float (M) 7
% Held by Insiders 24.29
% Held by Institutions 1.48
Shares Short (K) 644
Shares Short P. Month (K) 62

Stock Financials

EPS -1.480
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.970
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -4
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -2.74
PEG Ratio
Price to Book value 2.06
Price to Sales
Price to Cash Flow -8.35

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.